Denali Advisors LLC Lowers Holdings in Procter & Gamble Company (The) $PG

Denali Advisors LLC lessened its stake in Procter & Gamble Company (The) (NYSE:PGFree Report) by 36.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 6,612 shares of the company’s stock after selling 3,841 shares during the quarter. Denali Advisors LLC’s holdings in Procter & Gamble were worth $1,016,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of Procter & Gamble by 1.4% in the second quarter. Vanguard Group Inc. now owns 233,211,283 shares of the company’s stock valued at $37,155,222,000 after purchasing an additional 3,189,111 shares during the period. Geode Capital Management LLC raised its position in shares of Procter & Gamble by 1.8% during the 2nd quarter. Geode Capital Management LLC now owns 59,415,933 shares of the company’s stock worth $9,439,341,000 after purchasing an additional 1,060,713 shares during the last quarter. Norges Bank purchased a new position in Procter & Gamble in the 2nd quarter valued at about $5,099,644,000. Charles Schwab Investment Management Inc. boosted its holdings in Procter & Gamble by 1.7% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 17,385,571 shares of the company’s stock worth $2,770,035,000 after buying an additional 294,673 shares during the last quarter. Finally, Invesco Ltd. increased its stake in Procter & Gamble by 21.4% during the 2nd quarter. Invesco Ltd. now owns 16,374,499 shares of the company’s stock worth $2,608,785,000 after buying an additional 2,880,895 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO Gary A. Coombe sold 36,093 shares of the firm’s stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $162.33, for a total transaction of $5,858,976.69. Following the sale, the chief executive officer owned 34,994 shares of the company’s stock, valued at approximately $5,680,576.02. This trade represents a 50.77% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Chairman Jon R. Moeller sold 162,232 shares of the business’s stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the sale, the chairman owned 319,385 shares of the company’s stock, valued at $51,884,093.25. This represents a 33.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 326,091 shares of company stock valued at $51,795,360 over the last ninety days. 0.20% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on PG. Jefferies Financial Group raised Procter & Gamble from a “hold” rating to a “buy” rating and lifted their price target for the stock from $156.00 to $179.00 in a research note on Tuesday, December 16th. Rothschild & Co Redburn lifted their target price on shares of Procter & Gamble from $155.00 to $157.00 and gave the stock a “neutral” rating in a research note on Friday, January 23rd. Barclays set a $155.00 target price on shares of Procter & Gamble in a report on Friday, January 16th. Morgan Stanley set a $175.00 price target on shares of Procter & Gamble in a research note on Monday, October 27th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a research note on Monday, December 29th. Thirteen investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and an average price target of $167.67.

Get Our Latest Analysis on Procter & Gamble

Procter & Gamble Trading Down 0.7%

NYSE PG opened at $160.11 on Tuesday. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $179.99. The stock has a market capitalization of $372.09 billion, a P/E ratio of 23.72, a PEG ratio of 5.32 and a beta of 0.38. The firm’s 50-day moving average is $147.57 and its two-hundred day moving average is $150.47. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.72 and a quick ratio of 0.51.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Thursday, January 22nd. The company reported $1.88 earnings per share for the quarter, beating analysts’ consensus estimates of $1.86 by $0.02. The business had revenue of $22.21 billion during the quarter, compared to analysts’ expectations of $22.36 billion. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The company’s revenue was up 1.5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.88 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, February 17th. Investors of record on Friday, January 23rd will be issued a $1.0568 dividend. The ex-dividend date of this dividend is Friday, January 23rd. This represents a $4.23 annualized dividend and a yield of 2.6%. Procter & Gamble’s dividend payout ratio (DPR) is 62.67%.

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.